Bridging over troubled waters: the doubling time and histological subtypes of thymic epithelial tumors

por Kashima, Jumpei, Okuma, Yusuke
Publicado 2020

Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma

por Kitadai, Rui, Okuma, Yusuke
Publicado 2021

Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis

por Kitadai, Rui, Okuma, Yusuke
Publicado 2022

Unarranged territory in uncommon EGFR mutations

por Fujii, Hiroyuki, Okuma, Yusuke
Publicado 2022

Onco-biome in pharmacotherapy for lung cancer: a narrative review

por Tateishi, Akiko T., Okuma, Yusuke
Publicado 2022

Lung cancer patients harboring epidermal growth factor receptor mutation among those infected by human immunodeficiency virus

por Okuma, Yusuke, Hosomi, Yukio, Imamura, Akifumi
Publicado 2014

A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report

por Kashima, Jumpei, Okuma, Yusuke, Hishima, Tsunekazu
Publicado 2016

Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report

por Hakozaki, Taiki, Okuma, Yusuke, Kashima, Jumpei
Publicado 2018

Ceritinib for an anaplastic lymphoma kinase rearrangement-positive patient previously treated with alectinib with poor performance status

por Kitadai, Rui, Okuma, Yusuke, Kawai, Shoko
Publicado 2018

Molecular and Morphological Profiling of Lung Cancer: A Foundation for “Next-Generation” Pathologists and Oncologists

por Kashima, Jumpei, Kitadai, Rui, Okuma, Yusuke
Publicado 2019

Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer

por Kawai, Shoko, Suzuki, Hiroe, Okuma, Yusuke
Publicado 2020

Clinical outcome of thymic lymphoepithelioma-like carcinoma: Case report of a 14-year-old male

por SEKIHARA, KUNIKO, OKUMA, YUSUKE, KAWAMOTO, HIROSHI, HOSOMI, YUKIO
Publicado 2014

Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review

por Hashimoto, Kana, Okuma, Yusuke, Hosomi, Yukio, Hishima, Tsunekazu
Publicado 2016

Crucial role of treatment with palliative intent for a patient with advanced thymic carcinoma

por NAGAMATA, MAKOTO, OKUMA, YUSUKE, YAMADA, YUKO, HOSOMI, YUKIO, HISHIMA, TSUNEKAZU
Publicado 2014

Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy

por Okuma, Yusuke, Saito, Makoto, Hosomi, Yukio, Sakuyama, Toshikazu, Okamura, Tatsuru
Publicado 2014

Alectinib for choroidal metastasis in a patient with crizotinib-resistant ALK rearranged positive non-small cell lung cancer

por Okuma, Yusuke, Tanaka, Yuichiro, Kamei, Tina, Hosomi, Yukio, Okamura, Tatsuru
Publicado 2015

Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment

por Kashima, Jumpei, Horio, Hirotoshi, Okuma, Yusuke, Hosomi, Yukio, Hishima, Tsunekazu
Publicado 2016

Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma

por Watanabe, Kageaki, Okuma, Yusuke, Kawai, Shoko, Nagamata, Makoto, Hosomi, Yukio
Publicado 2021

Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

por Okuma, Yusuke, Hosomi, Yukio, Miyamoto, Shingo, Shibuya, Masahiko, Okamura, Tatsuru, Hishima, Tsunekazu
Publicado 2016

Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

por Okuma, Yusuke, Hosomi, Yukio, Miyamoto, Shingo, Shibuya, Masahiko, Okamura, Tatsuru, Hishima, Tsunekazu
Publicado 2016